Cargando…

Radiation and Anti-Cancer Vaccines: A Winning Combination

The emerging combination of radiation therapy with vaccines is a promising new treatment plan in the fight against cancer. While many cancer vaccines such as MUC1, p53 CpG oligodeoxynucleotide, and SOX2 may be great candidates for antitumor vaccination, there still remain many investigations to be d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cadena, Alexandra, Cushman, Taylor R., Anderson, Clark, Barsoumian, Hampartsoum B., Welsh, James W., Cortez, Maria Angelica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874650/ https://www.ncbi.nlm.nih.gov/pubmed/29385680 http://dx.doi.org/10.3390/vaccines6010009

Ejemplares similares

Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
por: Schoenhals, Jonathan E., et al.
Publicado: (2018)

NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
por: Barsoumian, Hampartsoum B., et al.
Publicado: (2023)

NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
por: Barsoumian, Hampartsoum B., et al.
Publicado: (2023)

Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials
por: Chen, Dawei, et al.
Publicado: (2020)

Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer
por: He, Kewen, et al.
Publicado: (2021)

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
por: Barsoumian, Hampartsoum B, et al.
Publicado: (2020)

High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses
por: Barsoumian, Hampartsoum B., et al.
Publicado: (2022)

Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance
por: Ganjoo, Shonik, et al.
Publicado: (2022)

Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
por: Menon, Hari, et al.
Publicado: (2019)

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
por: Chen, Dawei, et al.
Publicado: (2020)

Toxicity of radiation and immunotherapy combinations
por: Verma, Vivek, et al.
Publicado: (2018)

The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
por: Ganjoo, Shonik, et al.
Publicado: (2023)

Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and Retention
por: Barsoumian, Hampartsoum B., et al.
Publicado: (2022)

Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
por: Younes, Ahmed I., et al.
Publicado: (2020)

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
por: Menon, Hari, et al.
Publicado: (2019)

A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model
por: Hu, Yun, et al.
Publicado: (2021)

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
por: Hu, Yun, et al.
Publicado: (2022)

Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches
por: Klein, Katherine, et al.
Publicado: (2020)

Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer
por: Hu, Yun, et al.
Publicado: (2022)

Pulsed radiotherapy to mitigate high tumor burden and generate immune memory
por: Sezen, Duygu, et al.
Publicado: (2022)

Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases
por: He, Kewen, et al.
Publicado: (2021)

4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4(+)CD25(+)FoxP3(+) T Regulatory Cell Suppression
por: Barsoumian, Hampartsoum B., et al.
Publicado: (2016)

Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell
por: El Rami, Fadi E., et al.
Publicado: (2020)

Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy
por: Cortez, Maria Angelica, et al.
Publicado: (2020)

Bone morphogenetic protein 7 promotes resistance to immunotherapy
por: Cortez, Maria Angelica, et al.
Publicado: (2020)

Artificial intelligence and cardiovascular imaging: A win–win combination
por: Badano, Luigi P., et al.
Publicado: (2020)

China and the European Union in Africa: win–win-lose or win–win-win?
por: Che, Dewei, et al.
Publicado: (2023)

Win-win-win management: making winning partners out of every member of an organisation
por: Graff, Philippe
Publicado: (1993)

Safety and communication, a winning combination
por: HSE Unit
Publicado: (2014)

Plasmodium falciparum finds the winning combination
por: Hengge, Alvan C.
Publicado: (2021)

Tumor kinetics prior to treatment correlate with response to checkpoint inhibitors
por: Cadena, Alexandra P, et al.
Publicado: (2015)

The Spirit of Competition: To Win or Not To Win
por: Szczepinska, Teresa, et al.
Publicado: (2013)

Win-win opportunities combining high yields with high multi-taxa biodiversity in tropical agroforestry
por: Wurz, Annemarie, et al.
Publicado: (2022)

The Truth About Win-Win Negotiating
por: Thompson, Leigh
Publicado: (2010)

Development and Validation of the Win-Win Scale
por: Zhang, Shan, et al.
Publicado: (2021)

Immunomodulation and COVID-19: Is There a Winning Combination?
por: Samavedam, Srinivas
Publicado: (2020)

GOING FOR THE WIN-WIN-WIN: HARNESSING THE POWER OF SENIOR VOLUNTEERISM TO ADDRESS DEMENTIA CARE AND PROMOTE HEALTH
por: Samus, Quincy M, et al.
Publicado: (2019)

Targeting WDR5: A WINning Anti-Cancer Strategy?
por: Aho, Erin R, et al.
Publicado: (2019)

Ombuds’ corner: Compromise or “win-win” solution?
por: Vincent Vuillemin
Publicado: (2011)

Oral systemic therapy: Not all “win-win”
por: Bhattacharyya, G. S.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fplds5bln8n7m34f2j1c892r7h